Mitochondria have emerged as critical therapeutic targets in a wide range of diseases. The detailed examination of this organelle, as well as the search for methods to efficiently address it, therefore, represent significant challenges. In this article, we present a simple and robust method for the functionalization of uncharged amine-based molecules to enable their intracellular transport and selective accumulation in mitochondria. To this end, we have synthesized a self-immolative spacer that is both sensitive to mitochondrial nitroreductase and incorporates a triphenylphosphonium vectorising moiety. To demonstrate the efficacy of this mitochondrial shuttling technology, we have designed, synthesized, and employed a fluorogenic probe that unambiguously validates the concept. An initial extension of this technology for therapeutic purposes is proposed through the intramitochondrial delivery of native doxorubicin, showing promising potential to overcome drug resistance mechanisms
